E. de Azambuja

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

E. de Azambuja
Jan 29, 2025, 10:11 | Blog
Evandro de Azambuja: The prognostic value of residual disease RD biology and gene expression after NAT in HER2-positive EBC
Evandro de Azambuja, BSMO President 2023-2026, shared on LinkedIn: "Our paper highlighting the prognostic value…
Jan 5, 2025, 18:21 | Insight
Elisa Agostinetto: Drug-drug interactions between palbociclib and PPI in breast cancer
Elisa Agostinetto, Medical Research Fellow at the University Hospital of Brussels, shared a post on…
Oct 14, 2024, 11:40 | Insight
Characteristics and clinical outcomes of Breast Cancer in young BRCA carriers
Dana-Farber’s Breast Oncology Center shared a post on X: “New study now out in ESMO…
Sep 24, 2024, 09:07 | Blog
Guilherme Nader Marta: Global study on young BRCA carriers with breast cancer
Guilherme Nader Marta, Oncology Fellow at Jules Bordet Institute, shared a post by Elisa Agostinetto,…
Sep 21, 2024, 09:35 | Blog
Elisa Agostinetto: Characteristics and clinical outcomes of breast cancer
Elisa Agostinetto shared a post on X, about recent paper published in ESMO Open: Characteristics…
Sep 14, 2024, 09:44 | Societies
Key factors in promoting Professional Wellbeing of the Healthcare Workforce - ESMO
European Society for Medical Oncology(ESMO) shared a post on LinkedIn: "What are the key factors in…
Jul 25, 2024, 13:49 | Insight
Luca Arecco: Impact of hormone receptor status and tumor subtypes on prognosis of breast cancer in young BRCA carriers
Luca Arecco, Medical Oncology Resident at IRCCS Ospedale Policlinico San Martino, on X: "Published in…
Jun 23, 2024, 14:32 | Blog
Impact of Hormone Receptor Status and Tumor Subtypes of Breast Cancer in Young BRCA Carriers
Matteo Lambertini shared a post by Annals of Oncology, on X: "Presented at ASCO24 by Luca Arecco and…
All: 8 Posts: 1 - 100
Special Coverage